Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential
Author:
Fan Dahua1, Liu Liping2, Wu Zhengzhi1, Cao Meiqun3
Affiliation:
1. The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China 2. Department of Hepatobiliary and Pancreas Surgery, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, Shenzhen, Guangdong, China 3. Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China
Abstract
Neurodegenerative diseases are among the most serious health problems affecting millions of people worldwide. Such diseases are characterized by a progressive degeneration and / or death of neurons in the central nervous system. Currently, there are no therapeutic approaches to cure or even halt the progression of neurodegenerative diseases. During the last two decades, much attention has been paid to the neuroprotective and anti-neurodegenerative activities of compounds isolated from natural products with high efficacy and low toxicity. Accumulating evidence indicates that berberine, an isoquinoline alkaloid isolated from traditional Chinese medicinal herbs, may act as a promising anti-neurodegenerative agent by inhibiting the activity of the most important pathogenic enzymes, ameliorating intracellular oxidative stress, attenuating neuroinflammation, triggering autophagy and protecting neurons against apoptotic cell death. This review attempts to summarize the current state of knowledge regarding the therapeutic potential of berberine against neurodegenerative diseases, with a focus on the molecular mechanisms that underlie its effects on Alzheimer’s, Parkinson’s and Huntington’s diseases.
Funder
Science and Technology Innovation Foundation of Shenzhen China Postdoctoral Science Foundation National Natural Science Foundation of China
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology,General Medicine
Reference286 articles.
1. Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H, Wang S, Wu J, Wang Y, Li Z, Liu J, Jiang JD. Nat Med, Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.,, 2004, 10,, 1344-1351,10.1038/nm1135 2. Imanshahidi M, Hosseinzadeh H. Phytother Res, Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine.,, 2008, 22,, 999-1012,10.1002/ptr.2399 3. Liu B, Li W, Chang Y, Dong W, Ni L. J Pharm Biomed Anal, Extraction of berberine from rhizome of Coptis chinensis Franch using supercritical fluid extraction.,, 2006, 41,, 1056-1060,10.1016/j.jpba.2006.01.034 4. Lee B, Sur B, Shim I, Lee H, Hahm DH. Korean J Physiol Pharmacol, Phellodendron amurense and its major alkaloid compound, berberine ameliorates scopolamine-induced neuronal impairment and memory dysfunction in rats.,, 2012, 16,, 79-89,10.4196/kjpp.2012.16.2.79 5. Gentry EJ, Jampani HB, Keshavarz-Shokri A, Morton MD, Velde DV, Telikepalli H, Mitscher LA, Shawar R, Humble D, Baker W. J Nat Prod, Antitubercular natural products: Berberine from the roots of commercial Hydrastis canadensis powder. Isolation of inactive 8-oxotetrahydrothalifendine, canadine, β-hydrastine, and two new quinic acid esters, hycandinic acid esters-1 and -2.,, 1998, 61,, 1187-1193,10.1021/np9701889
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|